Last edition
News about "metastatic breast cancer "
Daiichi Sankyo Files sNDA in Japan for ENHERTU Plus Pertuzumab in HER2-Positive Breast Cancer
Daiichi Sankyo has filed a supplemental NDA in Japan for ENHERTU plus Pertuzumab in HER2-positive breast cancer. If approved, this therapy could enter the first-line metastatic setting and has the potential to become a new standard of care.
<br />
Metastatic Breast Cancer | 08/10/2025 | By Dineshwori | 475
Roche Reports Positive Results from Phase III evERA Breast Cancer Study
Roche has announced positive results from the phase III evERA study evaluating its investigational oral selective oestrogen receptor degrader (SERD), giredestrant, in combination with everolimus in people with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer.
Metastatic Breast Cancer | 24/09/2025 | By Dineshwori | 130
Novartis Reports Double-Digit Sales Growth In Q2, Raises Full-Year Guidance
Novartis has reported a robust financial performance for the second quarter of 2025, with net sales reaching USD 14.1 billion, up 12 percent year-on-year.
Metastatic Breast Cancer | 17/07/2025 | By Dineshwori | 996
Zydus Gets Approval from COFEPRIS to Market Mamitra
Zydus Lifesciences has announced that COFEPRIS (Federal Commission for the Protection Against Sanitary Risk) has granted marketing approval for Mamitra, a Trastuzumab biosimilar.
Metastatic Breast Cancer | 31/07/2024 | By Aishwarya | 693
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy